Status:
TERMINATED
Prospective Multicentric Study Comparing the Acute Hemodynamic Effect of Three Modes of Stimulation in Cardiac Resynchronization Therapy Recipients
Lead Sponsor:
CMC Ambroise Paré
Conditions:
Heart Failure
Cardiac Resynchronization Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cardiac Resynchronization Therapy (CRT) is an established treatment for patients with systolic heart failure and bundle branch block, improving functional capacity, quality of life and reducing morbi-...
Detailed Description
This study is a non-randomized, prospective, interventional, multicentric study. Patients implanted with an Abbott ® CRT pacemaker or defibrillator since less than 3 months are eligible for the study...
Eligibility Criteria
Inclusion
- Patient older than 18
- Implantation of a CRT (CRT-P or CRT-D) less than 3 months before inclusion
- MPP and SyncAV-enabled ABBOTT Quadripolar CRT pacing system
- Patient who had signed an informed consent and is willing to comply with study requirements
- De novo implantation
- Patient covered by national healthcare insurance
Exclusion
- Permanent/persistant atrial fibrillation/ supra-ventricular tachycardia
- Pacing indication for 2nd or 3rd degree AV block
- Upgrading from non-CRT system
- Pregnant or breastfeeding women
- Adult under legal protection
Key Trial Info
Start Date :
April 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 18 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03779802
Start Date
April 23 2019
End Date
April 18 2020
Last Update
May 22 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gehm Site D'Eaubonne
Eaubonne, Val-d'Oise, France, 95600
2
Cmc Ambroise Pare
Neuilly-sur-Seine, France, 92200
3
CHU Poitiers
Poitiers, France